BK Virus DNA Unit Converter
BK Virus DNA Unit Converter
BK virus guideline thresholds are written in copies/mL, every current assay reports IU/mL, and the WHO standard meant to bridge them carries deletions that make some assays over-report between five- and tenfold.
BK virus DNA IU/mL → log₁₀
IU/mL → log₁₀ IU/mLPlasma BK virus DNA 3,400 IU/mL
What this page converts, and what it refuses to
- IU/mL and copies/mL
- IU/mL is calibrated to the 1st WHO International Standard for BK virus DNA, NIBSC 14/212, assigned 7.2 log₁₀ IU/mL on reconstitution, and is the only unit current assays report. copies/mL is the unit the guideline thresholds are written in, and no manufacturer or study publishes a BK virus factor between them, so this page offers none rather than inventing one
- 1,000 and 10,000 c/mL
- probable BK polyomavirus nephropathy (above 1,000 sustained beyond two weeks) and presumptive nephropathy (above 10,000), from the 2024 international consensus guideline. Both are followed by “or equivalent”, which is the guideline acknowledging that the unit question has no clean answer
- five- to tenfold
- the guideline’s own figure for how far an assay targeting the early viral gene region may over-report after conversion into international units, because the WHO standard carries large deletions in that region across most of its genome coverage
Worked example
Plasma BK virus DNA 3,400 IU/mL
log₁₀(3,400) = 3.53 log₁₀ IU/mL
That is 0.34 times the 10,000 presumptive-nephropathy threshold, and above the 1,000 probable one
If this assay targets the early viral gene region and over-reports fivefold, the comparable figure is 3,400 ÷ 5 = 680 IU/mL — below both thresholds
At tenfold it is 340 IU/mL, which is 2.53 log₁₀
The spread between 3,400 and 340 is a whole log, and it is a property of which region the assay amplifies rather than of the patient
A fall to 340 IU/mL on the SAME assay would instead be a genuine 1-log reduction — which is why the trend on one platform is what to read
Guideline thresholds, and the unit they are written in
| Definition | Plasma BK virus DNAemia | Unit as written |
|---|---|---|
| Probable BK polyomavirus nephropathy | above 1,000, sustained for more than two weeks | c/mL, or equivalent |
| Presumptive BK polyomavirus nephropathy | above 10,000 | c/mL, or equivalent |
Why the standard itself does not close the gap
| Finding | Consequence |
|---|---|
| The WHO international standard carries large deletions in the early viral gene region across roughly 80 to 90 per cent of its genome coverage | assays targeting that region under-quantify the calibrator |
| An under-quantified calibrator shifts the whole standard curve | the same assays then yield five- to tenfold higher BK virus loads once converted into international units |
| Extraction, assay chemistry and standard-curve calibration all differ between laboratories | intra- and inter-laboratory commutability is impaired even in a shared unit |
A threshold in one unit and an assay in another
BK polyomavirus nephropathy is monitored by plasma viral load, and the thresholds everyone works to are numbers: above 1,000 copies per millilitre sustained beyond two weeks for probable nephropathy, above 10,000 for presumptive. Both come from the 2024 international consensus guideline, and both are written in copies per millilitre followed by “or equivalent”. Meanwhile every current assay reports international units per millilitre and nothing else, calibrated to the 1st WHO International Standard for BK virus DNA, NIBSC 14/212 — assigned 7.2 log₁₀ IU/mL on reconstitution, and, like the cytomegalovirus and Epstein-Barr standards, assigning no copy equivalence whatsoever.
So the reader arrives with a result in one unit and a threshold in another, and no published factor connects them. This page therefore converts what can be converted — an absolute value to its base-10 logarithm, the scale the load is trended on — and declines to manufacture a copies figure. That is not pedantry: the two thresholds are an order of magnitude apart, and an assumed factor of 1 would silently place a patient on one side or the other.
It gets worse, and this is the fact worth taking away. Sequencing of the WHO standard found large deletions in the early viral gene region across roughly 80 to 90 per cent of its genome coverage. An assay targeting that region reads too little virus in the calibrator, which inflates the standard curve and so every patient result: the guideline states that such assays yield five- to tenfold higher loads after conversion into international units. That is up to a full log of systematic error, introduced by the material meant to remove it, and it depends only on which part of the genome a laboratory amplifies. The secondary figures above apply that correction — not because it is prescribable, but because its size should be visible beside the threshold.
What survives is the trend on one assay. A tenfold fall measured twice on one platform is a tenfold fall whatever the calibration offset, because a constant multiplier cancels in a ratio — the arithmetic is on the viral load log change calculator. A result is comparable only with results from the same assay; a change across platforms is not a change in the patient. Intervals and thresholds are method- and laboratory-dependent, and your own report’s interval, for the assay that produced the result, takes precedence. This supports a clinician’s judgement rather than replacing it: it is arithmetic on the figures entered, and knows nothing about the patient.
Frequently asked questions
How do I convert BK virus IU/mL to copies/mL?
You cannot, from published data. No manufacturer or study gives a copies-per-IU factor for BK virus, and NIBSC 14/212 assigns a potency in international units and no copy equivalence. This page converts IU/mL to its log₁₀ instead rather than inventing a factor.
What BK virus level defines nephropathy?
The 2024 international consensus guideline defines probable BK polyomavirus nephropathy as plasma DNAemia above 1,000 c/mL sustained for more than two weeks, and presumptive nephropathy as above 10,000 c/mL. Both are written in copies per millilitre, “or equivalent”.
Why might my BK virus result be five to ten times too high?
Because the WHO standard carries large deletions in the early viral gene region across most of its genome coverage. An assay amplifying that region under-quantifies the calibrator, and the guideline states such assays yield five- to tenfold higher loads once converted into international units. It depends on the assay’s target, not the patient.
Can I compare BK virus results from two laboratories?
Not safely, even in the same unit. The consensus guideline notes that specimen handling, nucleic acid extraction, assay performance and standard curve calibration all impair commutability between laboratories. Monitor a patient in one laboratory, on one assay.
Is a urine BK virus load interpreted the same way?
No. Urinary loads run orders of magnitude higher than plasma ones and the thresholds here are plasma figures. Plasma viraemia has a considerably higher positive predictive value for nephropathy than viruria, which is why it is the preferred specimen.
Related calculators
References
- Kotton CN, et al. The second international consensus guidelines on the management of BK polyomavirus in kidney transplantation. Transplantation. 2024;108(9):1834–66. (Probable BKPyV-nephropathy: plasma BKPyV-DNAemia above 1,000 c/mL sustained beyond two weeks; presumptive: above 10,000 c/mL — both written in copies/mL, “or equivalent”.)
- NIBSC. 1st WHO International Standard for BK Virus DNA, code 14/212: instructions for use. Potters Bar: National Institute for Biological Standards and Control. (7.2 log₁₀ IU/mL on reconstitution; no copy equivalence is assigned.)
- SeraCare / LGC Clinical Diagnostics. AccuSpan BKV Linearity Panel datasheet 2410-0344. (Roche cobas BKV, 21.5–100,000,000 IU/mL; results in log IU/mL only, with no copies/mL equivalence given.)
Not medical advice. For healthcare professionals and education. Reference intervals vary by laboratory and assay — always use your own laboratory's. Never base a dose or a treatment decision on this page alone. Full disclaimer at calcengines.com/disclaimer/